Target Price | $1,125.00 |
Price | $2.04 |
Potential |
55,047.10%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a ZIOPHARM Oncology, Inc. price target 2025.
The average ZIOPHARM Oncology, Inc. target price is $1,125.00.
This is
55,047.10%
register free of charge
|
|
A rating was issued by 2 analysts: 0 Analysts recommend ZIOPHARM Oncology, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the ZIOPHARM Oncology, Inc. stock has an average upside potential 2025 of
55,047.10%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -21.97 | -0.60 |
741.76% | 97.27% | |
P/E | negative |
1 Analysts have issued a ZIOPHARM Oncology, Inc. forecast for earnings per share. The average ZIOPHARM Oncology, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
2023 | $-21.97 | 741.76% |
---|---|---|
2024 |
$-0.60
97.27%
Unlock
|
Current | -0.17 | 69.09% |
---|---|---|
2024 |
-3.10
1,723.53%
Unlock
|
ZIOPHARM Oncology, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.